For experts on stroke, Fetterman-Oz debate is a teachable moment; meet biotech's newest odd couple

"Even if someone is having trouble retrieving words or names, a person's intelligence can still be intact," an expert noted after the debate. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      For experts on stroke, Fetterman-Oz debate is a teachable moment By Andrew Joseph KRISTON JAE BETHEL/AFP via Getty Images Language stumbles like those shown by John Fetterman are often separate from any potential impact on cognitive ability, experts said. Read More When it comes to addiction, Americans' word choices are part of the problem By Lev Facher Hyacinth Empinado/STAT There's a push to swap out terms like "addict" or "substance abuse" in favor of language that recognizes addiction as a medical condition. Read More STAT+: Biotech's newest odd couple: A pharma insider and a music maven launch a health care VC By Allison DeAngelis Courtesy Stefan Simchowitz Tim Wright and D.A. Wallach have forged an unlikely alliance based on their shared interest in health care and investment. Read More Sponsored Insight by National Consumers League Protect patients' healthcare privacy and genetic data The U.S. Department of Defense recently listed BGI as a Chinese military company operating in the United States. American health information collected by BGI has no legal protection against disclosure to the Chinese government. The healthcare community must ensure patients' health records and genetic data are protected and not used for nefarious purposes, including genetically targeted bioweapons and bio-surveillance. Learn more at protectmypatientdata.com. Opinion: Listen: Home health care is facing devastating 'clawbacks' By Patrick Skerrett Medicare has proposed deep cuts to home health care and clawbacks to care provided during the pandemic, when it was needed the most. Read More STAT+: Q&A: A health justice lawyer and new MacArthur 'genius' on pharma's patent games By Ambar Castillo MacArthur Foundation “What we need to do now is ... understand: Why did [pharma] have this much power in the first place? And patents are the first place to look.” Read More Opinion: After 30 years of 340B, it's time for data and an honest conversation By John Michael O'Brien Adobe Stock The 340B Drug Discount Program is now a giant federal program. But it's impossible to tell where the money is going. That needs to change. Read More Wednesday, October 26, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser